Protein kinase inhibitor ceritinib blocks ectonucleotidase CD39 – a promising target for cancer immunotherapyLaura Schäkel, Christa E. Müller, Haneen Al-Hroub et al.|Journal for ImmunoTherapy of Cancer|2022Cited by 34
Synthesis, Characterization, Interactions, and Immunomodulatory Function of Ectonucleotidase CD39/CD73 Inhibitor 8-Butylthioadenosine 5′-MonophosphateChunyang Bi, Christa E. Müller, Laura Schäkel et al.|ACS Pharmacology & Translational Science|2025Cited by 5
Nucleotide-Derived Competitive Inhibitors of Ectonucleotidase CD39─A Promising Extracellular Target for Immunotherapy of CancerChunyang Bi, Christa E Müller, Constanze C. Schmies et al.|Journal of Medicinal Chemistry|2026Cited by 0